Original Articles

The Effect of COVID-19 Pandemic on Outcome of Assisted Reproductive Technology: A Report from a Single Infertility Center

Abstract

Objective: COVID-19 pandemic has affected all aspects of human life including social, economic, healthy behaviors and even individual relationships. This study aimed to investigate the effect of corona virus outbreak on assisted reproductive technology (ART) outcome.
Materials and methods: In this retrospective and prospective cohort, 260 ART cycles of ovum pick up (OPU), fresh embryo transfer (ET) and frozen embryo transfer (FET) were evaluated in 223 women (from December 2019 to February 2020) and during COVID-19 outbreak (February and July 2020) in an infertility center. Primary and secondary outcomes of ART cycles including chemical and clinical pregnancy rate were evaluated.
Results: The mean±SD (standard deviation) age of women was 34.17±6.56 years. Chemical and clinical pregnancy rates were 23.91% (33/138) per embryo transfer and 75.8% (25/33) per positive pregnancy test, respectively while ongoing pregnancy was seen only in 69.7% (23/33) of those with positive pregnancy test. Spontaneous abortion rate was 15.15% (5/33) per laboratory pregnancy. COVID-19 symptoms were reported in 2.83% and 15.38% of women during and after ART cycles, respectively.
Conclusion: It seems that COVID-19 pandemic has not negative effect on outcome of ART cycles except for cancelation rate due to COVID-19 that increased at the beginning of COVID-19 outbreak as it was unknown at that time and awareness was limited.

1. Vaiarelli A, Bulletti C, Cimadomo D, Borini A, Alviggi C, Ajossa S, et al. COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Reprod BioMed Online. 2020; 40: 755-9.
2. American Society of Reproductive Medicine. ASRM Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic: Update #5 2020.
3. ESHRE .Corona virus covid-19: ESHRE statement on pregnancy and conception. Fertil Steril. 2020; 114: 484-5.
4. La Marca A, Niederberger C, Pellicer A, Nelson SM. COVID-19: lessons from the Italian reproductive medical experience. Fertil Steril. 2020; 113: 920-2.
5. Sirohi B, Buckshee Rohatgi T, Lambertini M. Oncofertility and COVID-19—cancer does not wait. Ecancermedicalscience. 2020; 14: ed101.
6. Huang C, WangY, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.
7. Worldometer. COVID-19 Coronavirus Pandemic. 2020; Available from: https://www.worldometers.info/coronavirus/#countries.
8. Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, et al. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known? Fertil Steril 2020; 113: 1140-9.
9. Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum Reprod 2003; 18: 2089-92.
10. Jung A, Schuppe HC. Influence of genital heat stress on semen quality in humans. Andrologia 2007; 39: 203-15.
11. Practice Committee of American Society for Reproductive Medicine. Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Fertil Steril 2013; 99: 340-6.
12. Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol (Lausanne). 2019; 10: 814.
13. Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, et al. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology 2011. Fertil Steril. 2018; 110: 1067-80.
14. Li R, Yin T, Fang F, Li Q, Chen J, Wang Y, et al. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod Biomed Online 2020; 41: 89-95.
15. Veiga A, Gianaroli L, Ory S, Horton M, Feinberg E, Penzias A. Assisted reproduction and COVID-19: A joint statement of ASRM, ESHRE and IFFS. Fertil Steril 2020; 114: 484-5
16. Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. ESMO Open 2020; 5: e000759.
17. Dellino M, Minoia C, Virgilio Paradiso A, De Palo R, Silvestris E. Fertility Preservation in Cancer Patients During the Coronavirus (COVID-19) Pandemic. Front Oncol 2020; 10: 1009.
18. Eisenberg ML. Coronavirus disease 2019 and men’s reproductive health. Fertil Steril 2020; 113: 1154.
19. Li D, Jin M, Bao P, Zhao W, Zhang Sh. Clinical Characteristics and Results of Semen Tests Among Men with Coronavirus Disease 2019. JAMA Netw Open 2020; 3: e208292.
Files
IssueVol 16, No 1 (March 2022) QRcode
SectionOriginal Articles
DOI https://doi.org/10.18502/jfrh.v16i1.8598
Keywords
COVID-19 Pandemics Assisted Reproductive Technique Infertility
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Rashidi B, Bandarian M, Bandarian F, Tehraninejad E, Jafarabadi M. The Effect of COVID-19 Pandemic on Outcome of Assisted Reproductive Technology: A Report from a Single Infertility Center. J Family Reprod Health. 2022;16(1):86-92.